Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)

Not featured in screeners

Not featured in screeners

Top insiders

Download results Settings

Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

1 purchase — total 76,440 CAD

Buy 15 May 2018

Value CA$1,057,401.08 | Price 241.81 | Shares 16,560

Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

1 purchase — total 54,450 CAD

Buy 2 Apr 2018

Value CA$736,437.82 | Price 265.02 | Shares 65,514

Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

1 purchase — total 6,511 USD

Buy 29 Mar 2018

Value US$6,511.00 | Price 0.77 | Shares 8,500

Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

2 purchases — total 22,623 CAD

Buy 26 Feb 2018

Value CA$18,283.40 | Price 1.62 | Shares 11,300

Buy 26 Feb 2018

Value CA$4,340.00 | Price 1.74 | Shares 2,500

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2018-05-21	2018-05-15	B Purchase	2.6 Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director	16,560 241.81 CA$1,057,401	16,560	241.81	CA$1,057,401
2018-04-05	2018-04-02	B Purchase	2.6 Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director	65,514 265.02 CA$736,438	65,514	265.02	CA$736,438
2023-11-17	2018-03-29	B Purchase	2.6 Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director	99,469 +5.4% 427.49 US$4,464,150	99,469 +5.4%	427.49	US$4,464,150
2023-11-17	2018-02-26	B Purchase	2.6 Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director	11,300 +4.8% 1.62 CA$18,283	11,300 +4.8%	1.62	CA$18,283
2023-11-16	2018-02-26	B Purchase	2.6 Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director	2,500 +0.0% 1.74 CA$4,340	2,500 +0.0%	1.74	CA$4,340

More insider trading research around Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)